2m 2m 2m 2m 2m 2m 2m
Regeneron Pharma (REGN)
NASDAQ
$761.50-$1.13 (-0.15%)
Price as of Jul 31, 2026 7:49 PM EDT- $76.1BMarket Cap
- 37.21%1-Year Change
- BiotechnologyIndustry
Regeneron Pharma (REGN)
$761.50-$1.13 (-0.15%)
REGN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $762.63 | ||
Change | +$24.29 (+3.29%) | ||
Open | $726.69 | ||
High | $764.75 | ||
Low | $724.79 | ||
Previous Close | $738.34 | ||
Volume | 1,158,585 | ||
30-Day Average Volume | 816,319 | ||
1-Week Change | 16.25% | ||
1-Month Change | 22.31% | ||
1-Year Change | 37.21% | ||
3-Year Change | 3.64% | ||
5-Year Change | 33.82% | ||
Fundamentals | |||
Shares Outstanding | 103.0M | ||
Total Assets | $41.7B | ||
Market Cap | $76.1B | ||
Enterprise Value | $75.6B | ||
Period: QTR TTM FY | |||
Revenue | $1.6B | ||
Net Income | $1.3B | ||
Free Cash Flow | $572.8M | ||
EBIT | $1.5B | ||
EBITDA | $1.7B | ||
Net Working Capital | $12.9B | ||
EPS | $12.23 | ||
Enterprise Value/EBITDA | 46 | ||
Enterprise Value/Revenue | 46 | ||
P/B | 2 | ||
P/E | 62 | ||
PEG | 1 | ||
Price/Free Cash Flow | 137 | ||
Price/Operating Cash Flow | 97 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 0.49% | ||
Trailing Annual Dividend Yield | 0.48% | ||
Ex-Dividend Date | 08/18/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield